{
  "label": "clinical_signal_03_ep_024",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:143db5951bfa627af63264796069cb4838232db7f51297efe89f1eb27bd0ae62",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:55:24.538561",
  "content": "## 2024-08-12 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 244\n- Active: 236\n- Screen Failures Cumulative: 49\n- Withdrawals Cumulative: 8\n\n#### Sites\n- Site 01\n  - Enrolled: 25\n  - Active: 25\n  - Statin Concomitant: 6\n- Site 02\n  - Enrolled: 18\n  - Active: 18\n  - Statin Concomitant: 5\n- Site 03\n  - Enrolled: 22\n  - Active: 22\n  - Statin Concomitant: 7\n- Site 04\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 5\n- Site 05\n  - Enrolled: 20\n  - Active: 20\n  - Statin Concomitant: 5\n- Site 06\n  - Enrolled: 14\n  - Active: 14\n  - Statin Concomitant: 4\n- Site 07\n  - Enrolled: 27\n  - Active: 27\n  - Statin Concomitant: 8\n- Site 08\n  - Enrolled: 18\n  - Active: 18\n  - Statin Concomitant: 5\n- Site 09\n  - Enrolled: 20\n  - Active: 20\n  - Statin Concomitant: 6\n- Site 10\n  - Enrolled: 16\n  - Active: 16\n  - Statin Concomitant: 4\n- Site 11\n  - Enrolled: 22\n  - Active: 22\n  - Statin Concomitant: 5\n- Site 12\n  - Enrolled: 18\n  - Active: 18\n  - Statin Concomitant: 5\n\n### Lab Panels\n#### Statin Subgroup\n- N: 53\n- ALT (U/L) Mean: 133.5\n- ALT (U/L) Median: 131.2\n- AST (U/L) Mean: 98.1\n- AST (U/L) Median: 96.3\n- Bilirubin (mg/dL) Mean: 2.08\n- Bilirubin (mg/dL) Median: 2.05\n- ALP (U/L) Mean: 71.4\n- ALP (U/L) Median: 70.4\n- Creatinine (mg/dL) Mean: 0.97\n- Creatinine (mg/dL) Median: 0.9\n- BUN (mg/dL) Mean: 16.8\n- BUN (mg/dL) Median: 16.2\n- WBC (K) Mean: 6.9\n- WBC (K) Median: 7.4\n- Platelets (K) Mean: 253\n- Platelets (K) Median: 237\n\n#### Non-Statin Subgroup\n- N: 120\n- ALT (U/L) Mean: 21.8\n- ALT (U/L) Median: 20.0\n- AST (U/L) Mean: 19.6\n- AST (U/L) Median: 18.7\n- Bilirubin (mg/dL) Mean: 0.79\n- Bilirubin (mg/dL) Median: 0.74\n- ALP (U/L) Mean: 52.3\n- ALP (U/L) Median: 69.0\n- Creatinine (mg/dL) Mean: 0.94\n- Creatinine (mg/dL) Median: 0.84\n- BUN (mg/dL) Mean: 15.3\n- BUN (mg/dL) Median: 12.6\n- WBC (K) Mean: 8.0\n- WBC (K) Median: 7.6\n- Platelets (K) Mean: 248\n- Platelets (K) Median: 246\n\n### Adverse Events\n- AE ID: AE-0095, Description: upper respiratory infection, Grade: 1, Relatedness: not related, Resolved: true, Subject Group: statin\n- AE ID: AE-0096, Description: fatigue, Grade: 1, Relatedness: unlikely related, Resolved: true, Subject Group: statin\n- AE ID: AE-0097, Description: nausea, Grade: 1, Relatedness: possibly related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0098, Description: headache, Grade: 1, Relatedness: possibly related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0099, Description: hepatocellular injury, Grade: 3, Relatedness: probably related, Resolved: false, Subject Group: statin\n- AE ID: AE-0100, Description: jaundice, Grade: 2, Relatedness: probably related, Resolved: true, Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 55\n- ACE Inhibitor Count: 27\n- Metformin Count: 22\n- PPI Count: 18\n- NSAID Count: 13\n- Other Count: 38\n\n### Protocol Deviations\n- PD ID: PD-048, Description: Eligibility criterion reassessed, subject confirmed eligible, Severity: minor, Site: site_11\n- PD ID: PD-049, Description: Lab sample mislabeled, corrected same day, Severity: minor, Site: site_08\n\n### Investigator Notes\n- IEC/IRB annual renewal submitted on schedule\n- Central lab results received within 48h turnaround\n- Query resolution rate at 94%\n- DSMB teleconference scheduled; cross-site statin subgroup hepatic data package compiled\n\n### Events\n- CRO quarterly oversight report submitted\n- IVRS system update deployed, randomization unaffected\n- DSMB meeting materials finalized and transmitted\n\n### Notes\n- Week 24: DSMB review pending. Statin subgroup hepatic data compiled across all sites.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_024",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-08-12T10:00:00",
    "phase": "root_cause",
    "signal_density": "high",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}